期刊档案 · CHEMISTRY, MEDICINAL-CHEMISTRY, MULTIDISCIPLINARY
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH
ISSN 0004-4172 · eISSN 2194-9387 · GERMANY
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH 影响因子 1.9（官网公布），订阅期刊，APC 约 3,620 美元。
研究范围
研究范围与定位
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH。按 OpenAlex 近年发文统计，该刊主要发表 Synthesis and biological activity、Analytical Methods in Pharmaceuticals、Antibiotics Pharmacokinetics and Efficacy 等主题的论文，这 3 个主题约占 28.1%，主导子领域为 Organic Chemistry。（根据 OpenAlex 主题统计与中科院分区数据生成）
Target ReadershipDrug Research is intended for scientists, clinicians, and professionals involved in drug discovery, drug development, translational medicine, pharmacology, toxicology, and the evaluation of therapeutic compounds. It serves researchers working with both novel and established drug molecules, as well as those engaged in clinical trials, industrial investigations, and the quantitative assessment of drug efficacy and safety.Journal Purpose and MissionDrug Research (formerly Arzneimittelforschung) is an international peer‑reviewed journal with expedited processing times presenting the very latest research results related to novel and established drug molecules and the evaluation of new drug development. A key focus of the publication is translational medicine and the application of biological discoveries in the development of drugs for use in the clinical environment. The journal also addresses the mathematical and statistical methods for evaluating results from industrial investigations and clinical trials.Types of Articles PublishedDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.Publication FrequencyDrug Research publishes 12 issues per annum.Subject and Content ScopeThe journal presents research related to novel and established drug molecules and the evaluation of new drug development. Its scope includes translational medicine and the application of biological discoveries to clinical drug development, as well as analytics applied to clinical trials, chemistry and biochemistry, clinical and experimental pharmacology, drug interactions, efficacy testing, pharmacodynamics, pharmacokinetics, teratology, and toxicology. It also encompasses the mathematical and statistical methods used to evaluate results from industrial investigations and clinical trials.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：CHEMISTRY, MEDICINAL-CHEMISTRY, MULTIDISCIPLINARY
主编 Thomas Gudermann出版商官网
编委会国家分布：中国大陆 2 位（约 13%）；主要国家 德国 8、中国 2、瑞士 2、韩国 1、法国 1（共 15 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Synthesis and biological activityChemistry10.8%
- Analytical Methods in PharmaceuticalsChemistry9.7%
- Antibiotics Pharmacokinetics and EfficacyMedicine7.6%
- Pharmaceutical studies and practicesMedicine5.9%
- Synthesis and Characterization of Heterocyclic CompoundsChemistry5.9%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics5.8%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance5.3%
- Synthesis and Biological EvaluationChemistry4.1%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）未收录
该期刊未被此版本分区表收录。
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
收录数据库：暂无记录。
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
SSCIEmbase出版商官网
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子（出版商公布）
- 1.9出版商官网 ·
- h-index
- 57OpenAlex ·
- i10-index
- 617OpenAlex ·
- 两年平均被引
- 0OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
费用与开放获取
版面费与开放获取政策
订阅期刊LetPub
订阅期刊，文章需订阅或购买阅读，通常不收取版面费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| 出版商官网 | EUR 3,390 / USD 3,620 | — | — |
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点5 项，摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- 3–6 个
- 参考文献格式
- 顺序编码制（按引用顺序编号）
- 首次投稿格式
- 允许不按期刊格式排版（free format）
- 投稿信（Cover letter）
- 必须提供
接收的文章类型13 种
- commentariesThe following manuscript types are published in Drug Research: Original Articles Reviews Commentaries未说明篇幅
- commentaryDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.未说明篇幅
- controversiesThe following manuscript types are published in Drug Research: Original Articles Reviews Commentaries Controversies未说明篇幅
- letterDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.未说明篇幅
- lettersThe following manuscript types are published in Drug Research: Original Articles Reviews Commentaries Controversies Opinion Papers Short Communications Letters未说明篇幅
- opinionDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.未说明篇幅
- opinion papersThe following manuscript types are published in Drug Research: Original Articles Reviews Commentaries Controversies Opinion Papers未说明篇幅
- original articleDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.未说明篇幅
- original articlesThe following manuscript types are published in Drug Research: Original Articles未说明篇幅
- reviewDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.未说明篇幅
- reviewsThe following manuscript types are published in Drug Research: Original Articles Reviews未说明篇幅
- short communicationDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.未说明篇幅
- short communicationsThe following manuscript types are published in Drug Research: Original Articles Reviews Commentaries Controversies Opinion Papers Short Communications未说明篇幅
官网政策摘录利益冲突、开放获取、预印本
- 利益冲突 Conflict of Interest
该期刊要求在在线投稿过程中声明所有作者的利益冲突，未声明或声明不完整可能导致不予发表。 模型中文摘要
Please state the conflicts of interest of all authors during the online submission process. Failure to do so or an incomplete declaration may result in non-publication.
原文 ↗出版商官网 ·- 开放获取 Publish Open Access
Thieme订阅期刊（包括Drug Research）的作者可选择支付文章处理费（APC）以开放获取方式发表文章，当前价格可在“APC”下的“Price List”中查询，该期刊适用“Hybrid Open Access”价格。 模型中文摘要
Authors of articles for all Thieme subscription journals – including, of course, Drug Research - have the option of paying an article processing charge (APC) so that their articles will be published on an Open Access basis. Learn more about Thieme’s Open Access program by visiting https://www.thieme.com/en-us/who-we-serve/authors/journals/open-access. For the current pricing, please go to “APC” an…
原文 ↗出版商官网 ·- 预印本 Preprint Server Statement
该期刊鼓励提交已以初稿版本存入预印本仓库（如Research Square、arXiv、medRxiv）的稿件，投稿时应在投稿信中注明预印本仓库的使用、说明存入与投稿之间稿件的调整或更新，并引用预印本（含DOI）作为参考文献。 模型中文摘要
Drug Research encourages the submission of manuscripts that have been deposited in an initial draft version in preprint repositories such as Research Square, arXiv, and medRxiv. Drafts of short conference abstracts or degree theses posted on the website of the degree-granting institution, and draft manuscripts deposited on authors’ or institutional websites are also welcome. All other prior public…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版国家或地区
- GERMANY
- ISSN
- 0004-4172
- 印刷版 ISSN
- 2194-9379
- 电子版 ISSN
- 2194-9387
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 ARZNEIMITTELFORSCHUNG-DRUG RESEARCH 的常见问题
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH 的影响因子是多少？
期刊官网公布的影响因子为 1.9，属期刊自述数据，LetPub 暂无该刊的影响因子记录，h-index 为 57。
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；关键词：3–6 个；参考文献格式：顺序编码制（按引用顺序编号）；首次投稿格式：允许不按期刊格式排版（free format）；投稿信：必须提供。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 15 位编委中，中国大陆 2 位（约 13%）；人数最多的国家是 德国（8 位）、中国（2 位）、瑞士（2 位）。统计按编委会页面列出的机构国家计，仅供参考。
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH 被哪些数据库收录？
期刊官网自述还被 SSCI、Embase 收录，该清单未与各数据库逐一核对。
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH 是开放获取期刊吗？版面费多少？
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH 为订阅期刊。APC 约 3,620 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。